Skip to main content

Ultragenyx Pharmaceutical Inc 10-Q for FY2024 Q1

Ultragenyx Pharmaceutical Inc. (RARE)

10-Q 2024-05-03 For: 2024-03-31
View Original
Added on April 09, 2026

About this 10-Q

Ultragenyx Pharmaceutical Inc filed this 10-Q on May 3, 2024, covering the quarter ended March 31, 2024 (FY2024 Q1).

Headline figures

Quarter ended March 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$108.83M
up 8.3% from $100.5M a year earlier
Net loss
$170.68M
compared with a net loss of $163.97M a year earlier
Diluted EPS
-$2.03
compared with -$2.33 a year earlier